Cargando…
Comparing blood versus tissue-based biomarkers expression in breast cancer patients
Molecular markers have been used as a tool for diagnostic approaches, staging, and evaluation of therapeutic responses in patients with cancer. Cancer molecular markers can also help clinicians to make decision on therapy and prognosis evaluation at the time of diagnosis. In the early diagnosis of b...
Autores principales: | Oloomi, Mana, Moazzezy, Neda, Bouzari, Saeid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7132155/ https://www.ncbi.nlm.nih.gov/pubmed/32274439 http://dx.doi.org/10.1016/j.heliyon.2020.e03728 |
Ejemplares similares
-
Comparative Study of Blood, Tissue and Serum Levels of Carcinoembryonic Antigen (CEA) Detection in Breast Cancer
por: Moazzezy, Neda, et al.
Publicado: (2019) -
Modulation of Molecular Biomarker Expression in Response to Chemotherapy in Invasive Ductal Carcinoma
por: Oloomi, Mana, et al.
Publicado: (2018) -
Effect of Shiga Toxin and Its Subunits on Cytokine Induction in Different Cell Lines
por: Moazzezy, Neda, et al.
Publicado: (2014) -
Protein Kinase Signaling by Shiga Toxin Subunits
por: Oloomi, Mana, et al.
Publicado: (2021) -
Inhibition and eradication activity of truncated α-defensin analogs against multidrug resistant uropathogenic Escherichia coli biofilm
por: Moazzezy, Neda, et al.
Publicado: (2020)